phrykt

Chemomab Therapeutics Ltd. (CMMB): who owns it and who trades it

As of Nov 16, 2026, CMMB insiders reported 2 open-market sales worth $6.5K and 2 purchases worth $20.2K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Neil Harris Cohen (Director), with $6.5K. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Chemomab Therapeutics

From the latest filings

Overall: more buying than selling. Famous investors mostly bought. Insiders was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, CMMB insiders reported $20.2K of open-market purchases and $6.5K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$20.2K
2 trades, 1 people
Sales, 12 months
$6.5K
2 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Aug 28, 2026
Filed Sep 1, 2026

Purchases and sales by month

$20.2K$20.2KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 28, 2026Neil Harris CohenDirectorSale1,000$2.80$2.8KForm 4
Aug 27, 2026Neil Harris CohenDirectorSale1,304$2.85$3.7KForm 4
May 29, 2026George Adi MorCEOPurchase4,878$2.05$10KForm 4
May 29, 2026George Adi MorCEOPurchase4,926$2.08$10.2KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
George Adi MorChief Executive Officer, Director$20.2K–May 29, 2026
Neil Harris CohenDirector–$6.5KAug 28, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CMMB short interest

5,139 CMMB shares are sold short. Over the last 12 reports the number of shares short went down 87%.

As of Oct 30, 2026, 5,139 CMMB shares were sold short, down 63.0% from the report before. At the average daily volume of 48,290 shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

0.02%May 15Jul 150.03%

Days to cover

1.0May 15Oct 304.6

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20265,139–-63%48,2901.0
Oct 15, 202613,889–+32%43,0291.0
Sep 30, 202610,544–-87%215,4721.0
Sep 15, 202681,947–-20%83,2131.0
Aug 31, 2026102,705–-9%139,8341.0
Aug 14, 2026113,157–-27%58,8821.9
Jul 31, 2026155,604–+15%71,9082.2
Jul 15, 2026134,9090.02%-6%506,7161.0
Jun 30, 2026143,1440.02%+7%34,3784.2
Jun 15, 2026134,2750.02%+247%49,6332.7
May 29, 202638,6480.01%-3%50,8661.0
May 15, 202639,6490.01%-16%45,2691.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Chemomab Therapeutics financials

Famous investors that hold CMMB

2 of the 50 well-known investors we track reported holding CMMB in their latest 13F filing. The largest position is Ken Griffin's, worth $131K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026109,763$131K0.0%+15%
Jim Simons · Renaissance TechnologiesQ3 202610,328$12.3K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named CMMB in the last 120 days.

FiledHolderFormStake
Nov 10, 2026Scipher Medicine Corp13D10.4%
Nov 10, 2026Scipher Medicine Corp13D10.4%

Questions about Chemomab Therapeutics Ltd. (CMMB) stock

Are CMMB insiders buying or selling?

In the last 12 months, CMMB insiders reported 2 open-market purchases worth $20.2K and 2 sales worth $6.5K. The latest trade was on Aug 28, 2026. See every trade.

What is the short interest in CMMB?

As of Oct 30, 2026, 5,139 CMMB shares were sold short, down 63.0% from the report before. At the average daily volume of 48,290 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Which famous investors hold CMMB?

2 of the 50 well-known investors we track reported CMMB in their latest 13F filing, including Ken Griffin, Jim Simons. The largest position is worth $131K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.